Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Virological and Immunological Monitoring of Human Cytomegalovirus (HCMV) Infection in Hematopoietic Stem Cell Transplantation Recipients (HSCTR)

Elisa Gabanti, Roberta Sciarra, MD, Oscar Borsani, MD, Giuseppe Gerna, Daniela Caldera, MD, Anna Amelia Colombo, MD, Emilio Paolo Alessandrino, MD, Paolo Bernasconi, MD, Daniele Lilleri

Blood (2019) 134 (Supplement_1): 4544.

https://doi.org/10.1182/blood-2019-129939

Published: 2019

Journal Articles

Comparing Costs Associated to Letermovir Prophylaxis Vs Ganciclovir Pre-Emptive Therapy in HCMV-Seropositive Patients Who Undergone to Hemopoietic Stem Cells Transplantation

Oscar Borsani, MD, Daniele Lilleri, Elisa Gabanti, Gabriela Cassinelli, Anna Amelia Colombo, MD, Daniela Caldera, MD, Emilio Paolo Alessandrino, MD, Paolo Bernasconi, MD

Blood (2019) 134 (Supplement_1): 5643.

https://doi.org/10.1182/blood-2019-124121

Published: 2019

Journal Articles

Veno-Occlusive Disease (VOD) after Hematopoietic Stem Cell Transplant (HSCR): Always a Catastrophic Illness?

Paolo Bernasconi, MD, Anna Amelia Colombo, MD, Daniela Caldera, MD, Oscar Borsani, MD

Blood (2019) 134 (Supplement_1): 5649.

https://doi.org/10.1182/blood-2019-125608

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Polycythemia Vera or Essential Thrombocythemia Transformed to Myelofibrosis or Acute Myeloid Leukemia: a Single Center Experience

Paolo Bernasconi, Anna Amelia Colombo, MD, Daniela Caldera, MD, Virginia Valeria Ferretti, Silvia Mangiacavalli, MD, Marta Ubezio, MD, Daniela Pietra, PhD, Elisa Rumi, MD, Ilaria Carola Casetti, MD, Matteo Davià, Marina Boni, Irene Dambruoso, Rita Zappatore

Blood (2017) 130 (Supplement 1): 5497.

https://doi.org/10.1182/blood.V130.Suppl_1.5497.5497

Published: 2017

Journal Articles

Can Allo-HSCT Improve the Poor Clinical Outcome of the “Internal Tandem Duplication” of the FLT3 Gene?

Paolo Bernasconi, MD, Catherine Klersy, MD, Anna Amelia Colombo, MD, Daniela Caldera, MD, Francesco Ripamonti, MD, Patrizia Zappasodi, MD, Barbara Rocca, BSc, Celeste Calvello, BSc, Matteo Giovanni Della Porta, Marianna Rossi, MD, Manuela Santantonio, MD, Irene Dambruoso, Rita Zappatore, PhD, Mirko Farina, Daniela Troletti, BSc, Marina Boni, Carlo Castagnola, MD, Emilio Paolo Alessandrino, MD

Blood (2014) 124 (21): 5938.

https://doi.org/10.1182/blood.V124.21.5938.5938

Published: 2014

Journal Articles

Late Relapse in Leukemia: Does the Niche Matter?

Paolo Bernasconi, Marina Boni, Paola Maria Cavigliano, PhD, Barbara Rocca, BSc, Rita Zappatore, PhD, Irene Dambruoso, Ilaria Giardini, PhD, Celeste Calvello, BSc, Marilena Caresana, PhD, Daniela Caldera, MD, Anna Amelia Colombo, MD, Manuela Santantonio, MD, Francesco Ripamonti, MD, Emilio Paolo Alessandrino, MD

Blood (2012) 120 (21): 4793.

https://doi.org/10.1182/blood.V120.21.4793.4793

Published: 2012

Journal Articles

Reduced Intensity Conditioning with Thiotepa and Fludarabine for Allogeneic Transplantation: Evidence for Low Toxicity and Long-Lasting Disease Control in MDS with Low/Intermediate-1 IPSS Score and in AML from MDS in Complete Remission.

Emilio Paolo Alessandrino, Luca Malcovati, Giorgio La Nasa, Paolo de Fabritiis, Massimo Bernardi, Paolo Di Bartolomeo, Paolo Bernasconi, Anna A Colombo, Daniela Caldera, Cristiana Pascutto, Patrizio Mazza, Franco Narni, Rosanna Scime’, Attilio Olivieri, Marco Casini, Andrea Bacigalupo for GITMO

Blood (2008) 112 (11): 3285.

https://doi.org/10.1182/blood.V112.11.3285.3285

Published: 2008

Journal Articles

Human Metapneumovirus Infection in Adult Patients after Allogeneic Hemopoietic Stem Cell Transplantation.

Anna A. Colombo, MD, Alessandra Algarotti, MD, Maurizia Debiaggi, PhD, Maurizio Parea, MD, Letizia Zenone Bragotti, MD, Paolo Bernasconi, MD, Daniela Caldera, MD, Filippo Canducci, MD, Mario Lazzarino, MD, Emilio P. Alessandrino, MD

Blood (2005) 106 (11): 3228.

https://doi.org/10.1182/blood.V106.11.3228.3228

Published: 2005

Journal Articles

High Dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma: Comparison of Four Preparative Regimens.

Emilio P. Alessandrino, MD, Letizia Zenone Bragotti, MD, Anna A. Colombo, MD, Alessandra Algarotti, MD, Paolo Bernasconi, MD, Margherita Maffioli, MD, Daniela Caldera, MD, Alessandro Corso, MD, Elisa Rumi, MD, Daniela Troletti, PhD, Mario Lazzarino

Blood (2005) 106 (11): 5489.

https://doi.org/10.1182/blood.V106.11.5489.5489

Published: 2005

Journal Articles

High incidence of symptomatic cytomegalovirus infection in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

Emilio Paolo Alessandrino, Marzia Varettoni, Anna Amelia Colombo, Daniela Caldera, Paolo Bernasconi, Luca Malcovati

Blood (2000) 95 (12): 4016–4018.

https://doi.org/10.1182/blood.V95.12.4016

Published: 2000

NARROW

Virological and Immunological Monitoring of Human Cytomegalovirus (HCMV) Infection in Hematopoietic Stem Cell Transplantation Recipients (HSCTR)

Comparing Costs Associated to Letermovir Prophylaxis Vs Ganciclovir Pre-Emptive Therapy in HCMV-Seropositive Patients Who Undergone to Hemopoietic Stem Cells Transplantation

Veno-Occlusive Disease (VOD) after Hematopoietic Stem Cell Transplant (HSCR): Always a Catastrophic Illness?

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Polycythemia Vera or Essential Thrombocythemia Transformed to Myelofibrosis or Acute Myeloid Leukemia: a Single Center Experience

Can Allo-HSCT Improve the Poor Clinical Outcome of the “Internal Tandem Duplication” of the FLT3 Gene?

Late Relapse in Leukemia: Does the Niche Matter?

Reduced Intensity Conditioning with Thiotepa and Fludarabine for Allogeneic Transplantation: Evidence for Low Toxicity and Long-Lasting Disease Control in MDS with Low/Intermediate-1 IPSS Score and in AML from MDS in Complete Remission.

Human Metapneumovirus Infection in Adult Patients after Allogeneic Hemopoietic Stem Cell Transplantation.

High Dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma: Comparison of Four Preparative Regimens.

High incidence of symptomatic cytomegalovirus infection in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only